These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 9050981)
1. The I1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease. Ernsberger P; Friedman JE; Koletsky RJ J Hypertens Suppl; 1997 Jan; 15(1):S9-23. PubMed ID: 9050981 [TBL] [Abstract][Full Text] [Related]
2. A novel mechanism of action for hypertension control: moxonidine as a selective I1-imidazoline agonist. Ernsberger P; Haxhiu MA; Graff LM; Collins LA; Dreshaj I; Grove DL; Graves ME; Schäfer SG; Christen MO Cardiovasc Drugs Ther; 1994 Mar; 8 Suppl 1():27-41. PubMed ID: 8068578 [TBL] [Abstract][Full Text] [Related]
3. Selective antihypertensive action of moxonidine is mediated mainly by I1-imidazoline receptors in the rostral ventrolateral medulla. Haxhiu MA; Dreshaj I; Schäfer SG; Ernsberger P J Cardiovasc Pharmacol; 1994; 24 Suppl 1():S1-8. PubMed ID: 7533221 [TBL] [Abstract][Full Text] [Related]
4. Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites. Ernsberger P; Damon TH; Graff LM; Schäfer SG; Christen MO J Pharmacol Exp Ther; 1993 Jan; 264(1):172-82. PubMed ID: 8380858 [TBL] [Abstract][Full Text] [Related]
5. Why imidazoline receptor modulator in the treatment of hypertension? Schäfer SG; Kaan EC; Christen MO; Löw-Kröger A; Mest HJ; Molderings GJ Ann N Y Acad Sci; 1995 Jul; 763():659-72. PubMed ID: 7677385 [TBL] [Abstract][Full Text] [Related]
6. Site-dependent inhibition of neuronal c-jun in the brainstem elicited by imidazoline I1 receptor activation: role in rilmenidine-evoked hypotension. Wang X; Li G; Abdel-Rahman AA Eur J Pharmacol; 2005 May; 514(2-3):191-9. PubMed ID: 15910806 [TBL] [Abstract][Full Text] [Related]
7. Analysis of the receptor involved in the central hypotensive effect of rilmenidine and moxonidine. Bock C; Niederhoffer N; Szabo B Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):262-71. PubMed ID: 10344524 [TBL] [Abstract][Full Text] [Related]
8. I1 imidazoline agonists. General clinical pharmacology of imidazoline receptors: implications for the treatment of the elderly. Prichard BN; Graham BR Drugs Aging; 2000 Aug; 17(2):133-59. PubMed ID: 10984201 [TBL] [Abstract][Full Text] [Related]
9. Pharmacology of moxonidine, an I1-imidazoline receptor agonist. Ziegler D; Haxhiu MA; Kaan EC; Papp JG; Ernsberger P J Cardiovasc Pharmacol; 1996; 27 Suppl 3():S26-37. PubMed ID: 8872297 [TBL] [Abstract][Full Text] [Related]
10. Responsiveness of α2-adrenoceptor/I1-imidazoline receptor in the rostral ventrolateral medulla to cardiovascular regulation is enhanced in conscious spontaneously hypertensive rat. Yamazato M; Nakamoto M; Sakima A; Yamazato Y; Takishita S; Ohya Y Clin Exp Hypertens; 2019; 41(3):255-262. PubMed ID: 29764227 [TBL] [Abstract][Full Text] [Related]
12. Moxonidine: a new antiadrenergic antihypertensive agent. Prichard BN; Graham BR; Owens CW J Hypertens Suppl; 1999 Aug; 17(3):S41-54. PubMed ID: 10489098 [TBL] [Abstract][Full Text] [Related]
13. Anti-hyperglycemic activity of moxonidine: metabolic and molecular effects in obese spontaneously hypertensive rats. Friedman JE; Ishizuka T; Liu S; Farrell CJ; Koletsky RJ; Bedol D; Ernsberger P Blood Press Suppl; 1998; 3():32-9. PubMed ID: 10321453 [TBL] [Abstract][Full Text] [Related]
14. The role of I(1)-imidazoline and alpha(2)-adrenergic receptors in the modulation of glucose metabolism in the spontaneously hypertensive obese rat model of metabolic syndrome X. Velliquette RA; Ernsberger P J Pharmacol Exp Ther; 2003 Aug; 306(2):646-57. PubMed ID: 12756274 [TBL] [Abstract][Full Text] [Related]
15. Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent. Prichard BN; Owens CW; Graham BR J Hum Hypertens; 1997 Aug; 11 Suppl 1():S29-45. PubMed ID: 9321737 [TBL] [Abstract][Full Text] [Related]
16. Central imidazoline (I1) receptors as targets of centrally acting antihypertensives: moxonidine and rilmenidine. van Zwieten PA J Hypertens; 1997 Feb; 15(2):117-25. PubMed ID: 9469786 [TBL] [Abstract][Full Text] [Related]
18. Role of medullary I1-imidazoline and alpha 2-adrenergic receptors in the antihypertensive responses evoked by central administration of clonidine analogs in conscious spontaneously hypertensive rats. Buccafusco JJ; Lapp CA; Westbrooks KL; Ernsberger P J Pharmacol Exp Ther; 1995 Jun; 273(3):1162-71. PubMed ID: 7791087 [TBL] [Abstract][Full Text] [Related]
19. Coupling of I1-imidazoline receptors to diacylglyceride accumulation in PC12 rat pheochromocytoma cells. Separovic D; Kester M; Ernsberger P Mol Pharmacol; 1996 Apr; 49(4):668-75. PubMed ID: 8609895 [TBL] [Abstract][Full Text] [Related]
20. Relationship between imidazoline and alpha2-adrenoceptors involved in the sympatho-inhibitory actions of centrally acting antihypertensive agents. Head GA; Chan CK; Burke SL J Auton Nerv Syst; 1998 Oct; 72(2-3):163-9. PubMed ID: 9851565 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]